Previous Close
$2.57
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$319.4 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to ...
Community
- 0 posts discussing
0
Watchers
0
Visitors